Literature DB >> 11865446

Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease?

Oliver Liesenfeld1.   

Abstract

Infection with Toxoplasma gondii is naturally acquired through the oral route by ingestion of undercooked or raw meat containing cysts of the parasite or through ingestion of contaminated water or food contaminated with cysts or oocysts. Following peroral infection with 100 cysts of the ME49 strain of T. gondii, C57BL/6 mice die within 13 days after infection, whereas BALB/c mice survive. At day 7 of infection, massive necrosis of the villi and mucosal cells in the ilea is observed in C57BL/6 but not BALB/c mice. CD4(+) T cells, interferon-gamma, tumor necrosis factor-alpha, and inducible nitric oxide synthase mediate the development of necrosis. These findings indicate a Th1-type immunopathology, with parasite replication appearing to be involved in the first 3 days of infection. Murine and human studies on the immunopathogenesis of inflammatory bowel disease (e.g., Crohn's disease) also indicate a Th1-type immunopathology. The shared and distinct features of oral infection of mice with T. gondii and murine models of inflammatory bowel disease are discussed herein.

Entities:  

Mesh:

Year:  2002        PMID: 11865446     DOI: 10.1086/338006

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  67 in total

Review 1.  Monocytes mediate mucosal immunity to Toxoplasma gondii.

Authors:  Ildiko R Dunay; L David Sibley
Journal:  Curr Opin Immunol       Date:  2010-05-27       Impact factor: 7.486

2.  Oral oocyst-induced mouse model of toxoplasmosis: effect of infection with Toxoplasma gondii strains of different genotypes, dose, and mouse strains (transgenic, out-bred, in-bred) on pathogenesis and mortality.

Authors:  J P Dubey; L R Ferreira; J Martins; Rima McLeod
Journal:  Parasitology       Date:  2011-11-14       Impact factor: 3.234

3.  Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18.

Authors:  D Struck; I Frank; S Enders; U Steinhoff; C Schmidt; A Stallmach; O Liesenfeld; M M Heimesaat
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

4.  IL-1R Regulates Disease Tolerance and Cachexia in Toxoplasma gondii Infection.

Authors:  Stephanie J Melchor; Claire M Saunders; Imani Sanders; Jessica A Hatter; Kari A Byrnes; Sheryl Coutermarsh-Ott; Sarah E Ewald
Journal:  J Immunol       Date:  2020-04-29       Impact factor: 5.422

Review 5.  Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger.

Authors:  Charlotte E Egan; Sara B Cohen; Eric Y Denkers
Journal:  Immunol Cell Biol       Date:  2011-11-08       Impact factor: 5.126

6.  Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity.

Authors:  Emerson Soares Bernardes; Neide M Silva; Luciana Pereira Ruas; Jose Roberto Mineo; Adriano Motta Loyola; Daniel K Hsu; Fu-Tong Liu; Roger Chammas; Maria Cristina Roque-Barreira
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

7.  Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli.

Authors:  M M Heimesaat; A Fischer; H-K Jahn; J Niebergall; M Freudenberg; M Blaut; O Liesenfeld; R R Schumann; U B Göbel; S Bereswill
Journal:  Gut       Date:  2007-01-25       Impact factor: 23.059

Review 8.  Functional aspects of Toll-like receptor/MyD88 signalling during protozoan infection: focus on Toxoplasma gondii.

Authors:  C E Egan; W Sukhumavasi; B A Butcher; E Y Denkers
Journal:  Clin Exp Immunol       Date:  2009-01-21       Impact factor: 4.330

9.  Tim-3 is differently expressed in genetically susceptible C57BL/6 and resistant BALB/c mice during oral infection with Toxoplasma gondii.

Authors:  L C Berrocal Almanza; M Muñoz; A A Kühl; T Kamradt; M M Heimesaat; O Liesenfeld
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-09-23

10.  miR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression.

Authors:  Thelma M Escobar; Chrysi Kanellopoulou; David G Kugler; Gokhul Kilaru; Cuong K Nguyen; Vijayaraj Nagarajan; Ravikiran K Bhairavabhotla; Daniel Northrup; Rami Zahr; Patrick Burr; Xiuhuai Liu; Keji Zhao; Alan Sher; Dragana Jankovic; Jinfang Zhu; Stefan A Muljo
Journal:  Immunity       Date:  2014-05-22       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.